|Last Price$47.00||Day Change (%)-0.47%|
|Open Price$47.14||Day Change ($)-0.22|
|Day Range46.67–47.14||52-Week Range36.65–47.88|
As of Tue 3/3/2015 3:51:00 PM | USD
A group of top managers continue to keep looking for good investment opportunities, while taking full advantage of a rising (and potentially overvalued) market to book some gains.
Research and Markets: Generic Drugs a $350 Billion Opportunity According to 'The Generic Drugs Market: 2015-2030 - Opportunities, Challenges, Strategies & Forecasts'
Mylan Completes Acquisition Of Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business
Simple formulas for foreign exposure lose luster.
Research and Markets: Active Pharmaceutical Ingredients (API) Market in the US 2015-2019 with Abbott Laboratories , Aurobindo Pharma, Mylan & Teva Pharmaceutical Industries Dominating
The proposed Salix acquisition boosts our fair value estimate significantly.
Research and Markets: In Vitro Diagnostics (POC/Rapid diagnostics) Global Market - Forecast to 2020
Abbott Labs ABT had a strong showing at the American College of Cardiology's annual meeting this weekend, but the news was less positive for Boston Scientific BSX and partner Angiotech ANPI. Abbott revealed data from a head-to-head trial that demonstrated its Xience V drug-eluting stent performed ...
Research and Markets: Cardiac Marker Diagnostic Testing Markets 2015
Research and Markets: $173 Billion Wearable Technology Market Report 2015-2020 - Analysis of 221 Companies Offering 132 Different Wearable Technology Products